Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.

Javier Rodríguez-Carrio,Agata Burska,P G Conaghan,Willem A Dik,Robert Biesen,Maija-Leena Eloranta,Giulio Cavalli,Marianne Visser,Dimitrios T Boumpas,George Bertsias,Marie Wahren-Herlenius,Jan Rehwinkel,Marie-Louise Frémond,Mary K Crow,Lars Ronnblom,Ed Vital,Marjan Versnel

RMD open（2023）

引用 7|浏览24

暂无评分

摘要

Evidence indicates potential clinical value of assays measuring IFN-I pathway activation in several RMDs, but assay harmonisation and clinical validation are urged. This review informs the EULAR points to consider for the measurement and reporting of IFN-I pathway assays.

查看译文

关键词

arthritis, rheumatoid,autoimmunity,cytokines,immune system diseases,lupus erythematosus, systemic

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要